Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT03876223
- Status
- Recruiting
Conditions
- Coronary Microvascular Dysfunction
- Heart Failure With Preserved Ejection Fraction (HFpEF)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to examine small vessel disease (a condition in which the small arteries in the heart become narrowed). The investigators want to know how the small vessel disease contributes to pre-HFpEF (a condition with inadequate heart muscle function in the setting of preserved muscle pumping) and to better identify potential treatment for prevention of HFpEF. The main procedures of this study include up to 2 clinic visits (initial visit and a second clinical visit only if participants are unable to complete all research procedures at the initial visit); a 6-week phone interview visit, 4 quarterly follow-up phone interview visits in year 1; year 1 follow up cardiac MRI based on availability and ongoing annual follow-up phone interview visits to track progress. If participants choose to take part in this study, participants direct participation will end after 1 year, participants will then have the option of participating in ongoing annual check-in calls. Participants will be asked to undergo a physical exam and provide a completed medical history; complete a Cardiovascular (or Cardiac) Magnetic Resonance Imaging (CMRI) with contrast agent; complete questionnaires to describe heart symptoms and overall quality of life status; undergo blood draws to provide blood samples for research testing, and allow the study team to have access to medical records.
Key Dates
- Start date
- Jul 24, 2019
- Status verified
- Jun 2025
- Primary completion
- Feb 28, 2026
- Completion
- Feb 28, 2026
Study Design
- Enrollment
- 180 participants (estimated)
Primary Outcome Measure
CMR imaging [ Time Frame: Baseline, Annual follow up ]
Central Contacts
- Nicole Tovar310-248-6960
- Lorena Guzman3102486960
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | |
| University of Florida | Gainesville | Florida | 32610 | Eileen Handberg, PhD |
Find similar trials in Los Angeles, CA
Related Studies
- Coronary Microvascular Disease (CMD) RegistryRecruiting · Medstar Health Research Institute · Washington D.C., District of Columbia
- ELEVATE-HFpEF Clinical StudyRecruiting · Medtronic Cardiac Rhythm and Heart Failure · Phoenix, Arizona
- A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)PHASE1 · Recruiting · Vasa Therapeutics · Little Rock, Arkansas
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection FractionEARLY_PHASE1 · Recruiting · University of Florida · Gainesville, Florida